University of Colorado, Denver | GenomeWeb

University of Colorado, Denver

The organizations in the consortium will identify, characterize, and catalog human biological molecules affected by physical activity in volunteer biosamples.

Vanderbilt University, the University of Colorado at Denver, Partners HealthCare, and the Montreal Heart Institute will use Illumina technology to analyze their biobank samples.

The new findings point towards creating different treatment strategies for combating the disease in old and young patient groups. 

The partners will evaluate whether circulating tumor DNA profiling has use for monitoring treatment response and relapse in melanoma patients. 

Tech Transfer Tidbits

Premium

Kauffman Foundation, MIT, BioAMPS, University of Colorado, Endo Pharma, Harvard, Galapagos, Flanders Institute of Biotechnology, and more …

Funding from the National Institutes of Health for all proteomics-related research shrank by almost 3 percent in fiscal 2008, according to an analysis of NIH data by ProteoMonitor.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.